Moreover, through a systematic analysis of all breast cancer subtypes in all racial groups of patients, we have determined that MKK3 upregulation correlates uniquely with the poor survival of Black/African American patients specifically with the TNBC, and not with any other race or other breast cancer subtypes (Additional file 1: Table S9). The gene discussed is MAP2K3; the disease is breast carcinoma.